PhoreMost introduces GlueSEEKER platform for discovery of molecular glue degraders

FHS
May 22, 2024
5:58 am

PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKER™.

Filament Health Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation | Psychedelic Invest

VANCOUVER, BC, March 19, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, announced that

March 19, 2024

Africa faces growing cholera crisis amid underfunded control plans

Climate change and conflict are fuelling a resurgence of cholera in Africa, with progress toward elimination undermined by chronic underfunding, according to new analysis.

February 22, 2025

GoPro GPRO stock analysis & What to Expect with GPRO stock

August 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.